These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 23670164)

  • 1. Botulinum toxin for conditions of the female pelvis: comment.
    Israfil-Bayli F; Burton C; Parsons M; Bulchandani S; Toozs-Hobson P
    Int Urogynecol J; 2013 Aug; 24(8):1417. PubMed ID: 23670164
    [No Abstract]   [Full Text] [Related]  

  • 2. Botulinum toxin for conditions of the female pelvis.
    El-Khawand D; Wehbe S; Whitmore K
    Int Urogynecol J; 2013 Jul; 24(7):1073-81. PubMed ID: 23344218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Botulinum toxin in urology].
    Gamé X; Karsenty G
    Prog Urol; 2006 Nov; 16(4 Suppl FMC):24-7. PubMed ID: 17183968
    [No Abstract]   [Full Text] [Related]  

  • 4. Botulinum toxin: the overall cure for defective relaxation?
    Thumshirn M; Fried M
    Endoscopy; 1999 Jun; 31(5):392-7. PubMed ID: 10433051
    [No Abstract]   [Full Text] [Related]  

  • 5. Botulinum toxin in the management of bowel and bladder function in spinal cord injury and other neurologic disorders.
    Dykstra DD
    Phys Med Rehabil Clin N Am; 2003 Nov; 14(4):793-804, vi. PubMed ID: 14580038
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.
    Brueseke TJ; Lane FL
    Am J Obstet Gynecol; 2012 Mar; 206(3):e7-8. PubMed ID: 22381609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Botulinum toxins for pain].
    Soinila S; Haanpää M
    Duodecim; 2011; 127(22):2425-30. PubMed ID: 22238920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Botulinum toxin treatment of urethral and bladder dysfunction.
    Chuang YC; Smith CP; Somogyi GT; Chancellor MB
    J Formos Med Assoc; 2003 Jan; 102(1):5-11. PubMed ID: 12684605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin in the management of lower urinary tract dysfunction: contemporary update.
    Cruz F; Silva C
    Curr Opin Urol; 2004 Nov; 14(6):329-34. PubMed ID: 15626874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Botulinum toxin for the treatment of lower urinary tract symptoms: a review.
    Sahai A; Khan M; Fowler CJ; Dasgupta P
    Neurourol Urodyn; 2005; 24(1):2-12. PubMed ID: 15578628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Botulinum toxin for spastic GI disorders.
    Brisinda G; Maria G
    Gastrointest Endosc; 2003 Sep; 58(3):472-3. PubMed ID: 14528238
    [No Abstract]   [Full Text] [Related]  

  • 12. Emerging role of botulinum toxin in the management of voiding dysfunction.
    Smith CP; Chancellor MB
    J Urol; 2004 Jun; 171(6 Pt 1):2128-37. PubMed ID: 15126771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin: new option for refractory lower urinary tract symptoms in women.
    Rickey LM; Kenton K
    Clin Obstet Gynecol; 2008 Mar; 51(1):176-86. PubMed ID: 18303512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Applications of botulin].
    Lindberg L; Kanerva M; Pitkäranta A; Ansaranta M; Ylitalo L; Aaltonen LM; Pakarinen M; Salmenkylä S
    Duodecim; 2011; 127(22):2431-43. PubMed ID: 22238921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Use of botulinum toxin in the treatment of lower urinary tract disorders. Current status. Editorial comment].
    Bustamante Alarma S
    Arch Esp Urol; 2010 Dec; 63(10):842-3. PubMed ID: 21187565
    [No Abstract]   [Full Text] [Related]  

  • 16. Botulinum toxin to treat pelvic pain.
    Zhang Y; Smith CP
    Toxicon; 2018 Jun; 147():129-133. PubMed ID: 28847706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of botulinum toxin in the treatment of refractory overactive bladder.
    Mucksavage P; Smith AL; Moy ML
    Ostomy Wound Manage; 2006 Dec; 52(12):28, 30, 32-3. PubMed ID: 17219700
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of intractable tardive lingual dyskinesia with botulinum toxin.
    Beckmann YY; Seçil Y; Saka S; Kuserli A; Çiftçi Y
    J Clin Psychopharmacol; 2011 Apr; 31(2):250-1. PubMed ID: 21364341
    [No Abstract]   [Full Text] [Related]  

  • 19. Dystonias and botulinum toxin.
    Khadilkar SV
    J Assoc Physicians India; 2003 May; 51():443-4. PubMed ID: 12974422
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines for the therapeutic use of botulinum toxin in movement disorders.
    Pagni CA
    Ital J Neurol Sci; 1998 Jun; 19(3):189-90. PubMed ID: 10933476
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.